Melanoma and Other Malignant Neoplasms of Skin Active Not Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0081890 (Melanoma and Other Malignant Neoplasms of Skin)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02816021Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic MelanomaTreatment